145 related articles for article (PubMed ID: 11304989)
1. [Beta-lactam and macrolide resistance in Streptococcus pneumoniae].
Shibasaki Y; Ubukata K
Nihon Rinsho; 2001 Apr; 59(4):681-6. PubMed ID: 11304989
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the macrolide resistance gene in penicillin-resistant Streptococcus pneumoniae].
Tomita A; Shinoda Y; Yasuhara T; Wakuta R; Fukuchi K; Gomi K
Rinsho Byori; 2006 Aug; 54(8):792-9. PubMed ID: 16989397
[TBL] [Abstract][Full Text] [Related]
5. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae.
Hiramatsu K; Ohama M; Mijajima Y; Kishi K; Mizunoe S; Tokimatsu I; Nagai H; Kadota J; Saikawa T; Nasu M
Int J Antimicrob Agents; 2004 Aug; 24(2):125-9. PubMed ID: 15288310
[TBL] [Abstract][Full Text] [Related]
8. [A mass-spectrometric analysis of genetic markers of S. pneumoniae resistance to beta-lactam antibiotics].
Savinova TA; Il'ina EN; Sidorenko SV
Mol Gen Mikrobiol Virusol; 2010; (3):16-25. PubMed ID: 20882772
[TBL] [Abstract][Full Text] [Related]
9. [Drug-resistant bacteria of current topics and their resistance mechanisms--PRSP and BLNAR].
Ubukata K
Rinsho Byori; 2000 Jan; Suppl 111():17-25. PubMed ID: 10804788
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
11. Application of the real-time PCR method for genotypic identification of β-lactam resistance in isolates from invasive pneumococcal diseases.
Chiba N; Morozumi M; Ubukata K
Microb Drug Resist; 2012 Apr; 18(2):149-56. PubMed ID: 22029728
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
[TBL] [Abstract][Full Text] [Related]
13. [Effects of amino acid substitutions of penicillin-binding proteins 2B, 1A, 2X on minimal inhibitory concentration of beta-lactams against Streptococcus pneumoniae].
Xu M; Zhang JH; Ding YF; Tao YZ; Wang ZC
Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):60-4. PubMed ID: 20441706
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae.
Contreras-Martel C; Job V; Di Guilmi AM; Vernet T; Dideberg O; Dessen A
J Mol Biol; 2006 Jan; 355(4):684-96. PubMed ID: 16316661
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of pbp1a and pbp2b in clinical Streptococcus pneumoniae isolates in Quebec, Canada.
Granger D; Boily-Larouche G; Turgeon P; Weiss K; Roger M
J Antimicrob Chemother; 2006 Jan; 57(1):61-70. PubMed ID: 16282207
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of pbp2x in clinical Streptococcus pneumoniae isolates in Quebec, Canada.
Granger D; Boily-Larouche G; Turgeon P; Weiss K; Roger M
J Antimicrob Chemother; 2005 Jun; 55(6):832-9. PubMed ID: 15872046
[TBL] [Abstract][Full Text] [Related]
17. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
18. Trends in the activity of macrolide and beta-lactam antibiotics and resistance development. Alexander Project Group.
Schito GC; Mannelli S; Pesce A
J Chemother; 1997 May; 9 Suppl 3():18-28. PubMed ID: 9248977
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic resistance of clinical isolates Streptococcus pneumoniae].
Komori T; Takabayashi T; Kuse T; Nishino K; Suzuki K; Fujita N; Yoshimura M
Rinsho Byori; 1996 May; 44(5):465-70. PubMed ID: 8676567
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics.
Yamaguchi T; Hashikita G; Takahashi S; Itabashi A; Yamazaki T; Maesaki S
J Infect Chemother; 2005 Oct; 11(5):262-4. PubMed ID: 16258826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
